2022-03-07 - Cancer Synoptic Reporting Project Group Meeting
Cancer Synoptic Reporting Project Group
07 March 2022 at 17:30 UTC
Attendees @Scott Campbell @Former user (Deleted) @Jim Case @Stefan Dubois @Ian Green @Daniel Karlsson @Nicola Ingram @Paul @Laszlo Igali
@Suzanne Santamaria @Elaine Wooler
Meeting Recording (GoogleDrive)
https://drive.google.com/file/d/1wdGncF08y5Pv82UGgnZPhcBXGzAJK0Cd/view?usp=sharing
Discussion items
Item | Description | Owner | Notes | Action |
|---|
Item | Description | Owner | Notes | Action |
|---|---|---|---|---|
1 | Treatment effect | @Scott Campbell | Continue discussion: What are we measuring when assessing "treatment effect"? Is this a histologic change? Viability of tumor cells?
Note: SSA wonders about property in this model |
Will review model. This observable pertains to the process of regression/change in the neoplasm after antineoplastic therapy. So, observable could be modeled as presence of process changes.
Still a discussion. What is being measured? (Degree of presence of tumor). Can this be reproduced...base question is tumor there or not s/p therapy...tumor gone is best...everything else is questionable for the patient |
2 | Patterns | @Scott Campbell |
| We can use the morphologic descriptors...maybe...TBD |
3 | Lymph nodes | @Scott Campbell @Stefan Dubois |
2. Management of observables for lymph node involvement. Example: |
|
4 | AJCC update? | @Jim Case | Any updates that can be shared? | @Jim Case meeting with AJCC on Wednesday 26-Jan to continue/finalize contract issues |
Meeting Files
Previous Meetings
| Title | Creator | Modified |
|---|---|---|
| No content found. | ||
Copyright © 2025, SNOMED International